Top Back to top

Complications after CD19 CAR T-Cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

Transplant Complications Working Party (TCWP)
Study type:
Study number:
Type of Stem Cell Treatment:
Short title:
Primary objective:
Investigate the incidence of complications after therapy with commercial CD19 CAR-T cell products.
Key inclusion criteria:
Patients 18 years of age or older undergoing CD19+ CAR-T cell therapy for LBCL before end of April 2021.
Principal investigator:
Olaf Penack